Advertisement
UK markets closed
  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     
  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     
  • CRUDE OIL

    79.21
    +0.83 (+1.06%)
     
  • GOLD FUTURES

    2,318.30
    -5.90 (-0.25%)
     
  • DOW

    39,063.22
    +178.96 (+0.46%)
     
  • Bitcoin GBP

    49,848.93
    -697.01 (-1.38%)
     
  • CMC Crypto 200

    1,317.32
    +22.64 (+1.75%)
     
  • NASDAQ Composite

    16,299.88
    -32.68 (-0.20%)
     
  • UK FTSE All Share

    4,544.24
    +21.25 (+0.47%)
     

Johnson & Johnson Receives Offer to Divest Sterilization Business

Johnson & Johnson Receives Offer to Divest Sterilization Business

On June 6, Johnson & Johnson (JNJ) announced it had received a $2.8 billion offer from Fortive (FTV) to sell its ASP (Advanced Sterilization Products) business, part of its subsidiary, Ethicon. Ethicon’s ASP business, a market leader in infection prevention solutions, generated sales of $775 million in fiscal 2017. Johnson & Johnson has 120 days to decide on the offer.